Balyasny Asset Management LLC Stryker Corp Call Options Transaction History

Balyasny Asset Management LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$324.3 - $354.67 $486,450 - $532,005	1,500 New	1,500 $510,000
Q4 2023 Feb 14, 2024	SELL	$253.85 - $299.46 $10.2 Million - $12 Million	-40,000 Reduced 61.54%	25,000 $7.49 Million
Q2 2023 Aug 14, 2023	BUY	$271.49 - $305.09 $6.79 Million - $7.63 Million	25,000 Added 62.5%	65,000 $19.8 Million
Q4 2022 Feb 14, 2023	BUY	$205.51 - $253.93 $8.22 Million - $10.2 Million	40,000 New	40,000 $9.78 Million
Q3 2021 Nov 15, 2021	SELL	$248.9 - $280.09 $721,810 - $812,260	-2,900 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$242.95 - $267.0 $23.6 Million - $25.9 Million	-97,100 Reduced 97.1%	2,900 $753,000
Q4 2017 Feb 14, 2018	BUY	$143.51 - $159.74 $14.4 Million - $16 Million	100,000	100,000 $15.5 Million

2,288

284M

1.36M

1.61M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $148B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.